Annovis Bio Files Patent Application for Method of Inhibiting, Preventing, or Treating Neurological Injuries Due to Viral and Other Infections Including COVID-19
News
Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
Phase 3 Program Can Advance and the Company Plans to Initiate Registration Studies in the Fourth Quarter of 2020
Ride Health Launches First Comprehensive COVID-19 Equipped Transportation Network for New York City Metropolitan Area
Keriton Kare Selected by Connecticut Children’s to Improve Quality and Safety of Feeding Management in Its NICU and PICU
While the Keriton Kare Mom app is designed to help mothers produce more breast milk, its chat and photo-sharing functions have proven to be a lifeline during the pandemic — allowing separated parents to stay engaged in the care and development of their children.
Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients
Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options
Serious bacterial infections among major causes of disability and death for people in healthcare settings.
Collaboration comes at critical time with studies showing bacterial infections present in half of deceased COVID-19 patients.
Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
Wellsheet Used by Physicians at Concord Hospital Battling COVID-19 Outbreak
Predictive Workflow Platform Provides Coronavirus Alerts, Clinical Visibility, and Reduces Time in the EHR and Reduces Physician Burnout